Kyndryl Holdings, Inc. (KD) stock
Close on Oct 30, 2026Market cap $3.01BP/E –Yield 0.00%
Earnings
Kyndryl's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Kyndryl's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q2 FY2027ended Sep 30, 2026 | Nov 3, 2026Expected | – | – | – | – | – |
| Q1 FY2027ended Jun 30, 2026 | Aug 5, 2026before the open | $3.60B | -3.7% | -$0.25 | -$0.12 | Release |
| Q4 FY2026ended Mar 31, 2026 | May 6, 2026before the open | $3.80B | 0.0% | $0.08 | $0.18 | Release |
| Q3 FY2026ended Dec 31, 2025 | Feb 9, 2026before the open | $3.90B | +4.3% | $0.25 | $0.52 | Release |
| Q2 FY2026ended Sep 30, 2025 | Nov 4, 2025during market hours | $3.70B | -2.6% | – | – | Release |
| Q1 FY2026ended Jun 30, 2025 | Aug 4, 2025during market hours | $3.74B | 0.0% | – | – | Release |
| Q4 FY2025ended Mar 31, 2025 | May 7, 2025during market hours | $3.80B | 0.0% | – | – | Release |
| Q3 FY2025ended Dec 31, 2024 | Feb 3, 2025during market hours | $3.74B | -4.1% | $0.89 | $0.51 | Release |
| Q2 FY2025ended Sep 30, 2024 | Nov 6, 2024during market hours | $3.80B | -7.3% | – | – | Release |
| Q1 FY2025ended Jun 30, 2024 | Jul 31, 2024during market hours | $3.74B | -11.0% | $0.05 | – | Release |
| Q4 FY2024ended Mar 31, 2024 | May 7, 2024during market hours | $3.80B | – | -$0.20 | – | Release |
| Q3 FY2024ended Dec 31, 2023 | Feb 6, 2024during market hours | $3.90B | – | -$0.05 | – | Release |
| Q2 FY2024ended Sep 30, 2023 | Nov 7, 2023during market hours | $4.10B | – | -$0.62 | -$0.05 | Release |
| Q1 FY2024ended Jun 30, 2023 | Aug 7, 2023during market hours | $4.20B | – | -$0.62 | – | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 28, 2022during market hours | $4.60B | – | -$3.30 | – | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 22, 2021during market hours | $4.58B | – | – | – | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Kyndryl's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Adjusted pretax incomenon-GAAP | FY2027 | $600.00M – $700.00M | – | New | Aug 5, 2026 |
| Free cash flownon-GAAP | FY2027 | $400.00M – $500.00M | $400.00M – $500.00M | Reaffirmed | Aug 5, 2026 |
| Adjusted pretax incomenon-GAAP | FY2027 | $600.00M – $700.00M | – | New | May 6, 2026 |
Guidance history
Every forecast Kyndryl put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Aug 5, 2026 | Free cash flow | FY2027 | $400.00M – $500.00M | Reaffirmed |
| Aug 5, 2026 | Adjusted pretax income | FY2027 | $600.00M – $700.00M | New |
| May 6, 2026 | Free cash flow | FY2027 | $400.00M – $500.00M | New |
| May 6, 2026 | Adjusted pretax income | FY2027 | $600.00M – $700.00M | New |
| Feb 9, 2026 | Free cash flow | FY2026 | $325.00M – $375.00M | Lowered |
| Feb 9, 2026 | Adjusted EBITDA margin | FY2026 | 17.5% | Lowered |
| Feb 9, 2026 | Adjusted pretax income | FY2026 | $575.00M – $600.00M | Lowered |
| Feb 9, 2026 | Constant-currency revenue decline | FY2026 | -3% – -2% | Lowered |
| Nov 4, 2025 | Free cash flow | FY2026 | $550.00M | Reaffirmed |
| Nov 4, 2025 | Adjusted EBITDA margin | FY2026 | 18% | Reaffirmed |
| Nov 4, 2025 | Adjusted pretax income | FY2026 | $725.00M | Reaffirmed |
| Nov 4, 2025 | Constant-currency revenue growth | FY2026 | +1% | Reaffirmed |
| Aug 4, 2025 | Free cash flow | FY2026 | $550.00M | Reaffirmed |
| Aug 4, 2025 | Adjusted EBITDA margin | FY2026 | 18% | New |
| Aug 4, 2025 | Adjusted pretax income | FY2026 | $725.00M | Reaffirmed |
| Aug 4, 2025 | Constant-currency revenue growth | FY2026 | +1% | Reaffirmed |
| May 7, 2025 | Adjusted free cash flow | FY2026 | $550.00M | New |
| May 7, 2025 | Adjusted EBITDA margin | FY2026 | 18% | New |
| May 7, 2025 | Adjusted pretax income | FY2026 | $725.00M | New |
| May 7, 2025 | constant-currency revenue growth | FY2026 | +1% | New |
| Feb 3, 2025 | Adjusted EBITDA margin | FY2025 | 16.7% | New |
| Feb 3, 2025 | Adjusted free cash flow | FY2025 | $350.00M | New |
| Feb 3, 2025 | Adjusted pretax income | FY2025 | $475.00M | New |
| Feb 3, 2025 | constant-currency revenue growth | Q4 FY2025 | +2% | New |
| Nov 6, 2024 | Adjusted free cash flow | FY2025 | $300.00M | Reaffirmed |
| Nov 6, 2024 | Adjusted EBITDA margin | FY2025 | 16.3% | Lowered |
| Nov 6, 2024 | Adjusted pretax income | FY2025 | $460.00M | Reaffirmed |
| Nov 6, 2024 | Constant-currency revenue growth | FY2025 | -4% – -2% | Reaffirmed |
| Nov 6, 2024 | revenue | FY2025 | $15.20B – $15.50B | Reaffirmed |
| Jul 31, 2024 | Adjusted EBITDA margin | FY2025 | 16.3% | Raised |
| Jul 31, 2024 | adjusted free cash flow | FY2025 | $300.00M | New |
| Jul 31, 2024 | Adjusted pretax income | FY2025 | $460.00M | Raised |
| Jul 31, 2024 | constant-currency revenue growth | FY2025 | -4% – -2% | Reaffirmed |
| Jul 31, 2024 | revenue | FY2025 | $15.20B – $15.50B | Reaffirmed |
| May 7, 2024 | Adjusted EBITDA margin | FY2025 | 16.2% | New |
| May 7, 2024 | Conversion of adjusted pretax income (less cash taxes) to adjusted free cash flow | FY2025 | 100% | New |
| May 7, 2024 | Adjusted pretax income | FY2025 | $435.00M | New |
| May 7, 2024 | Revenue growth | FY2025 | -4% – -2% | New |
| May 7, 2024 | revenue | FY2025 | $15.20B – $15.50B | New |
| Feb 6, 2024 | adjusted EBITDA margin | FY2024 | 14.5% | Raised |
| Feb 6, 2024 | adjusted pretax income | FY2024 | $150.00M | Raised |
| Feb 6, 2024 | constant-currency revenue growth | FY2024 | -7% – -6% | Reaffirmed |
| Nov 7, 2023 | adjusted EBITDA margin | FY2024 | 14.5% | New |
| Nov 7, 2023 | adjusted pretax income | FY2024 | $140.00M | Raised |
| Nov 7, 2023 | constant-currency revenue growth | FY2024 | -7% – -6% | New |
| Aug 7, 2023 | adjusted EBITDA margin | FY2024 | 14% | New |
| Aug 7, 2023 | adjusted pretax income | FY2024 | $100.00M | New |
| Feb 28, 2022 | Adjusted EBITDA margin | Q1 FY2022 | 12% – 13% | New |
| Feb 28, 2022 | Adjusted pretax margin | Q1 FY2022 | -1% | New |
| Feb 28, 2022 | Revenue decline | Q1 FY2022 | -5% | New |
| Nov 22, 2021 | Net capital expenditures | FY2021 | $600.00M – $800.00M | New |
| Nov 22, 2021 | Pro forma adjusted EBITDA | FY2021 | $2.80B – $2.90B | New |
| Nov 22, 2021 | Pro forma adjusted pretax income | FY2021 | $100.00M – $200.00M | New |
| Nov 22, 2021 | Pro forma revenue | FY2021 | $18.50B – $18.70B | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Kyndryl filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- Results
- Results
- Results
- Results
- Results
- Results
- Update
- Results
- Results
- Results
- Results
- Results
- Results